IL10 and benign prostatic hyperplasia: In our neurogenically hypertensive BPH/2J mice, we found that DAPA treatment reduced inflammation in the heart by significantly reducing the inflammatory cytokine IL-6, while at the same time increasing the anti-inflammatory cytokine Interleukin 10 (IL-10) [22].